I am seeking all information about the CO-200-201 trial that is supposed to start in Europe this year (PI-2301 copolymer, Peptimmune Incl. USA). There is no information on clinicaltrials.com.
Does anybody have details about the trial? (how is it designed, what phase, the main goal, age of participants, type of MS, inclusion and exclusion criteria, primary and secondary outcomes, etc...)
Thanks in advance!
PI-2301, copolymer
-
RuSmolikova
- Family Elder
- Posts: 163
- Joined: Thu Nov 01, 2007 3:00 pm
- Location: Prague
I did some searching, and couldn't come up with much. You may already know this information, but here's some links that mention their phase Ib study that apparently established safety, and their plans to do a phase II trial:
http://www.peptimmune.com/research_deve ... is/pi_2301
http://www.medicalnewstoday.com/articles/161838.php
Also, Squiffy had posted this:
http://www.msrc.co.uk/index.cfm?fuseact ... ageid=1397
Actually, if you want to get more information about their upcoming trials, maybe the best thing to do is call the company.
http://www.peptimmune.com/research_deve ... is/pi_2301
http://www.medicalnewstoday.com/articles/161838.php
Also, Squiffy had posted this:
http://www.msrc.co.uk/index.cfm?fuseact ... ageid=1397
Actually, if you want to get more information about their upcoming trials, maybe the best thing to do is call the company.